Research has revealed that MS4A8B protein expression is associated with tumor recurrence, Gleason scores, and proliferation indices (45), indicating that MS4A8B expression is related to postsurgical recurrence and metastasis in prostate cancer patients. Here, MS4A8 is linked to neoplasm.